Utility of bronchoalveolar lavage in the management of immunocompromised patients presenting with lung infiltrates
Open Access
- 26 February 2019
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 19 (1) , 51
Abstract
Bronchoalveolar lavage (BAL) is utilized for diagnosing lung infiltrates in immunocompromised. There is heterogeneity in the data and reported diagnostic yields range from 26 to 69%. Therefore, selection criteria for BAL to maximize yield and minimize complications are unclear. Objectives of this study were to determine the diagnostic yield and complication rate of BAL in immunocompromised patients presenting with lung infiltrates, and identify factors impacting these outcomes. Exploratory aims included characterization of pathogens, rate of treatment modification and mortality. Retrospective study from January 2012 to December 2016. Patients on mechanical ventilation were excluded. Positive diagnostic yield was defined as confirmed microbiological or cytological diagnosis. A total of 217 patients were recruited (70.1% male and mean age: 51.7 ± 14.6 years). Diagnostic yield was 60.8% and complication rate 14.7%. Complications (hypoxemia and endobronchial bleeding) were all sell-limiting. Treatment modification based on BAL results was 63.3%. In 97.0% an infectious aetiology was identified. HIV infection (OR 5.304, 95% CI 1.611–17.458, p = 0.006) and severe neutropenia (OR 4.253, 95% CI 1.288–14.045, p = 0.018) were associated with positive yield. Leukemia (OR 0.317, 95% CI 0.102–0.982, p = 0.047) was associated with lower yield. No factors impacted complication rate. Overall mortality (90-day) was 17.5% and in those with hematologic malignancy, it was 28.3%. BAL retains utility in diagnosis of immunocompromised patients with lung infiltrates. However, patients with hematologic malignancy have a high mortality and alternative sampling should be considered because of poor results with BAL. ClinicalTrials.gov identifier NCT01374542 . Registered June 16, 2011.Keywords
This publication has 30 references indexed in Scilit:
- Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patientsAnnals of Thoracic Medicine, 2013
- Pulmonary complications in the non-HIV immunocompromised patientClinical Radiology, 2012
- Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer centerCancer, 2011
- Retrospective utility of bronchoscopy after hematopoietic stem cell transplantBone Marrow Transplantation, 2006
- Infectious pulmonary complications after stem cell transplantation or chemotherapy: Diagnostic yield of bronchoalveolar lavageDiagnostic Microbiology and Infectious Disease, 2005
- Pulmonary Infiltrates in Immunosuppressed Patients: Analysis of a Diagnostic ProtocolJournal of Clinical Microbiology, 2002
- Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic proceduresThorax, 2001
- Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimenThorax, 2001
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Pulmonary Disease in the Immunocompromised Host (First of Two Parts)Mayo Clinic Proceedings, 1985